Research and Markets: Marine Biotechnology: Marine Biomaterials, Marine Bioactive Substances, and Others - Global Strategic Business Report

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mggp4p/marine) has announced the addition of the "Marine Biotechnology - Global Strategic Business Report" report to their offering.

“Marine Biotechnology - Global Strategic Business Report”

This report analyzes the Global markets for Marine Biotechnology in US$ Million by the following Product Segments: Marine Biomaterials, Marine Bioactive Substances, and Others. The major End-Use Applications analyzed are Industrial Products, Health Care/Biotechnology, Consumer Products, Public Services & Infrastructure, and Others. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for this market.

The report profiles 87 companies including many key and niche players such as Aker BioMarine ASA, Ashland Inc., CP Kelco US, Inc., Cyanotech Corp., Elan Corp, FMC Corp., FMC Biopolymers AS, GlycoMar Ltd., Lonza Group Ltd., MariCal, Marinova, Mera Pharmaceuticals Inc., New England Biolabs Inc., PharmaMar S.A, PML Applications Ltd., Prolume Ltd., Royal DSM N.V, Sea Run Holdings Inc., and Tequesta Marine Biosciences.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

1. INDUSTRY DYNAMICS

2. MARINE BIOTECHNOLOGY - AN OVERVIEW

3. REGIONAL MARKET OVERVIEW

4. PRODUCT INTRODUCTIONS/INNOVATIONS

5. RECENT INDUSTRY ACTIVITY

6. FOCUS ON SELECT PLAYERS

7. GLOBAL MARKET PERSPECTIVE

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 87 (including Divisions/Subsidiaries - 95)

Region/Country Players

• The United States 31
• Canada 4
• Japan 1
• Europe 37
• France 1
• Germany 4
• The United Kingdom 7
• Spain 1
• Rest of Europe 24
• Asia-Pacific (Excluding Japan) 20
• Middle-East 2

For more information visit http://www.researchandmarkets.com/research/mggp4p/marine